3705 Stock Overview
Through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics in Taiwan, Mainland China, Japan, and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
YungShin Global Holding Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NT$58.10 |
| 52 Week High | NT$63.30 |
| 52 Week Low | NT$45.40 |
| Beta | 0.065 |
| 11 Month Change | 1.57% |
| 3 Month Change | 2.83% |
| 1 Year Change | 27.69% |
| 33 Year Change | 33.72% |
| 5 Year Change | 36.87% |
| Change since IPO | 51.00% |
Recent News & Updates
Recent updates
YungShin Global Holding (TWSE:3705) Is Due To Pay A Dividend Of NT$2.30
Jun 20
YungShin Global Holding (TWSE:3705) Is Paying Out A Dividend Of NT$2.30
May 09YungShin Global Holding (TWSE:3705) Will Pay A Dividend Of NT$2.30
Apr 25YungShin Global Holding (TWSE:3705) Is Paying Out A Dividend Of NT$2.30
Apr 01With EPS Growth And More, YungShin Global Holding (TPE:3705) Is Interesting
Apr 05If You Had Bought YungShin Global Holding (TPE:3705) Stock A Year Ago, You Could Pocket A 10% Gain Today
Mar 16These 4 Measures Indicate That YungShin Global Holding (TPE:3705) Is Using Debt Reasonably Well
Feb 22Does YungShin Global Holding Corporation (TPE:3705) Have A Place In Your Dividend Portfolio?
Feb 05
YungShin Global Holding Corporation's (TPE:3705) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 18Here's Why I Think YungShin Global Holding (TPE:3705) Is An Interesting Stock
Dec 31If You Had Bought YungShin Global Holding (TPE:3705) Shares Three Years Ago You'd Have Earned 12% Returns
Dec 16YungShin Global Holding's (TPE:3705) Earnings Are Growing But Is There More To The Story?
Dec 01Shareholder Returns
| 3705 | TW Pharmaceuticals | TW Market | |
|---|---|---|---|
| 7D | 8.6% | 0.6% | -0.8% |
| 1Y | 27.7% | 9.2% | 29.0% |
Return vs Industry: 3705 exceeded the TW Pharmaceuticals industry which returned 9.2% over the past year.
Return vs Market: 3705 underperformed the TW Market which returned 29% over the past year.
Price Volatility
| 3705 volatility | |
|---|---|
| 3705 Average Weekly Movement | 3.9% |
| Pharmaceuticals Industry Average Movement | 3.8% |
| Market Average Movement | 4.5% |
| 10% most volatile stocks in TW Market | 8.0% |
| 10% least volatile stocks in TW Market | 2.1% |
Stable Share Price: 3705 has not had significant price volatility in the past 3 months compared to the TW market.
Volatility Over Time: 3705's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1952 | n/a | Chih-Wei Chien | www.yungshingroup.com |
YungShin Global Holding Corporation, through its subsidiaries, invests in, manufactures, and sells medicines, animal drugs, agricultural chemicals, industrial medicines, and cosmetics in Taiwan, Mainland China, Japan, and the United States. It also engages in the extraction, manufacture, and sale of wood products; manufacture and sale of over-the-counter drugs, preparations, and chemical intermediates; and pharmaceutical research, transfer, and authorization services, as well as import and export trading. In addition, the company is involved in the trading, wholesale, and retail of health products, cosmetics, medicines, human testing reagents, and the aforesaid related raw materials; semi-finished products; and production equipment.
YungShin Global Holding Corporation Fundamentals Summary
| 3705 fundamental statistics | |
|---|---|
| Market cap | NT$15.48b |
| Earnings (TTM) | NT$1.03b |
| Revenue (TTM) | NT$7.82b |
15.0x
P/E Ratio2.0x
P/S RatioIs 3705 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3705 income statement (TTM) | |
|---|---|
| Revenue | NT$7.82b |
| Cost of Revenue | NT$4.42b |
| Gross Profit | NT$3.40b |
| Other Expenses | NT$2.37b |
| Earnings | NT$1.03b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 3.86 |
| Gross Margin | 43.43% |
| Net Profit Margin | 13.16% |
| Debt/Equity Ratio | 14.6% |
How did 3705 perform over the long term?
See historical performance and comparison